Four years after being taken private, Parexel has been sold again, with Goldman Sachs' private equity arm and EQT paying $8.5 billion to claim ownership of the contract research organisation.

The clinical research organization Parexel has signed a lease for a 61,076-square-foot office to relocate its global ...

Parexel and Sanofi are to undertake research to find out just how useful wearables are for patients and investigators in clinical trials. The promise of wearables is that they can improve data ...